Reduced triphosphopyridine nucleotide oxidase-catalyzed alterations of membrane phospholipids. V. Use of erythrocytes to demonstrate enzyme-dependent production of a component with the properties of a free radical.
D000447:Aldehydes / Q000096:biosynthesis; D000818:Animals; D004355:Drug Stability; D004579:Electron Transport; D004912:Erythrocytes / Q000187:drug effects; D005609:Free Radicals; D006461:Hemolysis; D006358:Hot Temperature; D008099:Liver / Q000166:cytology; D008297:Male; D008314:Malonates / Q000096:biosynthesis; D008345:Manganese / Q000494:pharmacology; D008566:Membranes / Q000187:drug effects; D008862:Microsomes, Liver / Q000187:drug effects / Q000201:enzymology / Q000378:metabolism*; D009249:NADP / Q000378:metabolism*; D009996:Osmotic Fragility; D010088:Oxidoreductases; D010101:Oxygen Consumption / Q000187:drug effects; D010545:Peroxides / Q000494:pharmacology; D010743:Phospholipids / Q000378:metabolism; D051381:Rats; D014810:Vitamin E / Q000494:pharmacology
D000447:Aldehydes; D005609:Free Radicals; D008314:Malonates; D010545:Peroxides; D010743:Phospholipids; D014810:Vitamin E; D008345:Manganese; D009249:NADP; D010088:Oxidoreductases